TickerFiles

4D Molecular Therapeutics, Inc. SEC filings

FormCompanyFiledAccession
44D Molecular Therapeutics, Inc.2026-07-140001834021-26-000004
44D Molecular Therapeutics, Inc.2026-07-020001920738-26-000004
44D Molecular Therapeutics, Inc.2026-06-250001920738-26-000002
44D Molecular Therapeutics, Inc.2026-06-230001834021-26-000002
44D Molecular Therapeutics, Inc.2026-06-020001193125-26-253740
10-Q4D Molecular Therapeutics, Inc.2026-05-070001193125-26-211939
44D Molecular Therapeutics, Inc.2026-03-240001193125-26-122341
10-K4D Molecular Therapeutics, Inc.2026-03-180001193125-26-114075
44D Molecular Therapeutics, Inc.2025-12-230001193125-25-331299
44D Molecular Therapeutics, Inc.2025-12-190001193125-25-326851
44D Molecular Therapeutics, Inc.2025-12-160001193125-25-320992
44D Molecular Therapeutics, Inc.2025-11-190001193125-25-288632
10-Q4D Molecular Therapeutics, Inc.2025-11-100001193125-25-273343
44D Molecular Therapeutics, Inc.2025-10-270001193125-25-251874
44D Molecular Therapeutics, Inc.2025-10-200001193125-25-243946
44D Molecular Therapeutics, Inc.2025-10-140001193125-25-238995
44D Molecular Therapeutics, Inc.2025-09-260001193125-25-221028
10-Q4D Molecular Therapeutics, Inc.2025-08-110000950170-25-106244